N/A
Completed N=25
An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring
Circumference Reduction
Source: ClinicalTrials.gov NCT05674292 ↗
Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcomePrimary: Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs — -3.91 inches
Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs |
-3.91 | — |
Eligibility Criteria
Inclusion Criteria
- BMI is 30 or less
- 18 years of age or older
Exclusion Criteria
- Pregnant
- Open wounds (sores, cuts, ulcers, etc.)
- Individuals with or being treated for any cancerous growth
Data sourced from ClinicalTrials.gov (NCT05674292). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.